{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:16:52Z","timestamp":1789755412063,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ajog.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T10:36:01Z","timestamp":1339410961000},"page":"228.e1-228.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia"],"prefix":"10.1016","volume":"207","author":[{"given":"Richelle N.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Woelkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dunsmoor-Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Yvette","family":"LaCoursiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2012.06.006_bib1","first-page":"159","article-title":"ACOG Committee on Practice Bulletins\u2013Obstetrics","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib2","first-page":"24","article-title":"Pregnancy outcomes in healthy nulliparas who developed hypertension: calcium for preeclampsia prevention study group","volume":"95","author":"Hauth","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.HYP.0000054981.03589.E9","article-title":"Summary of the NHLBI working group on research on hypertension during pregnancy","volume":"41","author":"Roberts","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2012.06.006_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.06.006_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semperi.2005.06.006","article-title":"First and second trimester evaluation of risk for fetal aneuploidy: the secondary outcomes of the FASTER trial","volume":"29","author":"D'Alton","year":"2005","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2012.06.006_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000322742","article-title":"Early detection of preeclampsia using inhibin a and other second-trimester serum markers","volume":"29","author":"Ree","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2012.06.006_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2505","article-title":"Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome","volume":"30","author":"Huang","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.06.006_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/GCO.0b013e328344579c","article-title":"Contemporary prediction of preeclampsia","volume":"23","author":"Scazzocchio","year":"2011","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.06.006_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.304.6831.867","article-title":"Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy","volume":"304","author":"Nicolaides","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2012.06.006_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome","volume":"17","author":"Wald","year":"1997","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.06.006_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1975.tb25397.x","article-title":"Normal biology of alpha-fetoprotein","volume":"259","author":"Gitlin","year":"1975","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2012.06.006_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/pd.1970050405","article-title":"AFP transport across the fetal membranes in the human","volume":"5","author":"Los","year":"1985","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.06.006_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(82)90188-0","article-title":"Second-trimester placental changes associated with elevated maternal serum alpha-fetoprotein","volume":"144","author":"Perkes","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Obstetrical complications associated with abnormal maternal serum markers analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2012.06.006_bib18","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ajog.2006.03.011","article-title":"Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin","volume":"194","author":"Towner","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2004-831898","article-title":"Role of inhibin in normal and high-risk pregnancy","volume":"22","author":"Muttukrishna","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2012.06.006_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pd.2627","article-title":"Predicting the risk of pre-eclampsia between 11 and 13 weeks gestation by combining maternal characteristics and serum analytes, PAPP-A and free b-hCG","volume":"30","author":"Goetzinger","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.06.006_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2012.06.006_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2012.06.006_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","article-title":"Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review","volume":"66","author":"Kuc","year":"2001","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2012.06.006_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the national high blood pressure education program working group on high blood pressure in pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2012.06.006_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pd.2848","article-title":"Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (>34 weeks) pre-eclampsia","volume":"31","author":"Youssef","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.06.006_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/10641950903572282","article-title":"Are early and late preeclampsia distinct subclasses of the disease\u2013what does the placenta reveal?","volume":"29","author":"van der Merwe","year":"2010","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2012.06.006_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.06.006_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/14767050903258746","article-title":"Evidence for distinct preterm and term phenotypes of preeclampsia","volume":"23","author":"Phillips","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2012.06.006_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/aje\/155.3.203","article-title":"Impact of preeclampsia and gestational hypertension on birth weight by gestational age","volume":"155","author":"Xiong","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2012.06.006_bib32","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.006_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812005984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812005984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:46:31Z","timestamp":1757587591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937812005984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0002937812005984"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2012.06.006","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2012.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}